Feng Ling

Title: Feng Ling - Innovator in Pharmaceutical Composition

Introduction

Feng Ling is a notable inventor based in Xuzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the area of pain management. His innovative work focuses on addressing the challenges associated with morphine-induced analgesic tolerance.

Latest Patents

Feng Ling holds a patent for a pharmaceutical composition and method for relieving or eliminating morphine-induced analgesic tolerance. This patent includes a therapeutically effective amount of a short peptide and morphine as active ingredients, along with a pharmaceutically acceptable carrier. The short peptide consists of an amino acid sequence shown in SEQ ID NO: 1 or a pharmaceutically acceptable salt thereof. The method involves administering the short peptide and morphine to a subject simultaneously, or injecting the short peptide followed by morphine administration.

Career Highlights

Feng Ling is affiliated with Xuzhou Medical University, where he conducts research and develops innovative pharmaceutical solutions. His work has garnered attention for its potential to improve pain management strategies and enhance patient outcomes.

Collaborations

Feng collaborates with colleagues such as Chen Chen and Long Ma, contributing to a dynamic research environment focused on pharmaceutical advancements.

Conclusion

Feng Ling's contributions to the field of pharmaceuticals, particularly through his patent addressing morphine-induced analgesic tolerance, highlight his role as an innovator in pain management. His work at Xuzhou Medical University continues to pave the way for future advancements in this critical area of healthcare.